Sarepta's $401 Million Quarter Anchors Healthcare Gains as Volatility and Inflation ETFs PivotGlobal Report·Aug 21 at 05:12 AMSRTA+2.70%BMEZ-0.15%
Givaudan SA (OTCMKTS:GVDNY) Sees Significant Decrease in Short InterestMarket Beat·Aug 11 at 10:40 PMGVDNY-2.74%
Market Miscellany Overhaul: Robotics SPAC Mergers and Biotech NDA SubmissionsGlobal Report·Jul 28 at 04:12 AMCCXI-2.90%MNPR+2.03%
Orr Reiterates Hold on Givaudan as Strong Top-Line Momentum Is Offset by Weaker Cash Generation and Margin PressureTip Ranks·Jul 23 at 07:26 AMGVDNY-2.74%
Givaudan H1 Profit, Sales Down; Backs LFL Sales Growth View Aheadrttnews·Jul 23 at 12:08 AMGVDNY-2.74%
GIVN: Solid LFL sales growth and resilient margins, but profits and cash flow declined amid higher costsQuartr·Jul 23 at 12:06 AMGVDNY-2.74%
03:19 ETHerb & Spice Extracts Market Outlook 2036 with Key Contributions from Givaudan, Kerry Group, McCormick & Company, Sensient Technologies, and Symriseprnewswire·Apr 29 at 02:20 AMKRYAY-1.56%GVDNY-2.74%
